Evidence map›Paper›PMID 33343633›Full record

ArticleFrontiers in genetics2020

Sanger Validation of High-Throughput Sequencing in Genetic Diagnosis: Still the Best Practice?

Rosina De Cario, Ada Kura, Samuele Suraci, Alberto Magi, Andrea Volta, Rossella Marcucci, Anna Maria Gori, Guglielmina Pepe, Betti Giusti, Elena Sticchi

Abstract read
In one paragraph

Article in Frontiers in genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Sanger validation of WGS variants.Scientific reports · 2025
    Article
  11. Review
  12. Allelic dropout in the endoglin (Frontiers in genetics · 2025
    Article
  13. Targeted Next-Generation Sequencing in Rare Diseases.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  14. Article
  15. Article
  16. The CARD9 Gene in Koalas (Journal of fungi (Basel, Switzerland) · 2024
    Article
  17. Article
  18. Genetic characterization of intramuscular myxomas.Pathology oncology research : POR · 2024
    Article
  19. International journal of microbiology · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rosina De CarioDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Ada KuraDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Samuele SuraciDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Alberto MagiDepartment of Information Engineering, University of Florence, Florence, Italy.
Andrea VoltaDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Rossella MarcucciDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Anna Maria GoriDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Guglielmina PepeDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Betti GiustiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Elena SticchiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Next-generation sequencing (NGS)'s crucial role in supporting genetic diagnosis and personalized medicine leads to the definition of Guidelines for Diagnostic NGS by the European Society of Human Genetics. Factors of different nature producing false-positive/negative NGS data together with the paucity of internationally accepted guidelines providing specified NGS quality metrics to be followed for diagnostics purpose made the Sanger validation of NGS variants still mandatory. We reported the analysis of three cases of discrepancy between NGS and Sanger sequencing in a cohort of 218 patients. NGS was performed by Illumina MiSeq

Indexed as

allelic drop-outdiscrepancyhigh-throughput sequencingnext generation sequencingSanger sequencingsequencing validationvariant call quality

Identifiers

PMID33343633
PMCPMC7738558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.